The company's Q3 profit increased 16 per cent year-on-year (Y-o-Y) to Rs 360.78 crore as compared to Rs 310.98 crore ...

StockNews.com upgraded shares of Abbott Laboratories (NYSE:ABT – Free Report) from a buy rating to a strong-buy rating in a ...

The FDA announced the approval of a new treatment for pneumonia caused by certain difficult-to-treat bacteria, offering hope ...

One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have diabetes.' New survey results and a film released today by Abbott highlight how ...

MTG Aetherdrift cards focus on a few major things: vehicles, speed, and vehicles again. However, somehow, the best cards are ...

Abbott India jumped 6.17% to Rs 27,756.50 after the company's net profit increased 16.01% to Rs 360.78 crore in Q3 FY25 as against Rs 310.98 crore posted in Q3 FY24.

Its current CEO is Miles White. Abbott is now comprised of four equally-sized businesses – diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. According to its ...

Abbott announced new four-year data showing the long-term and sustained relief that its proprietary BurstDR™ spinal cord stimulation (SCS) technology provides people with chronic pain, particularly ...

Texas Governor Greg Abbott has issued an executive order banning Diversity, Equity, and Inclusion (DEI) policies in all state agencies, emphasizing merit-based advancement over race-based preferences.

4 Abbott's other technologies span the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 ...

Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on January 31st, the Senator disclosed that they had sold between $1,001 and $15,000 ...